Clinical trial
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
NCT02603146
Study timeline
Study start (actual)2016-04-27Date precision: day
Registry last updated2025-06-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Healthy Participantsunresolved
Rheumatoid Arthritis (RA) Preventionunresolved
Interventions
HydroxychloroquineDRUG · verified · RxNorm: hydroxychloroquine
HCQ PlaceboDRUG
Sponsors & collaborators
Autoimmunity Centers of Excellencecollaborator
Mapped research locations
Los AngelesCalifornia, United States2BostonMassachusetts, United States1DallasTexas, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1BirminghamAlabama, United States1AuroraColorado, United States1Oklahoma CityOklahoma, United States1OmahaNebraska, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1WorcesterMassachusetts, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02603146 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.